- Home
- Publications
- Publication Search
- Publication Details
Title
Medical cannabis: Another piece in the mosaic of autoimmunity?
Authors
Keywords
-
Journal
CLINICAL PHARMACOLOGY & THERAPEUTICS
Volume 101, Issue 2, Pages 230-238
Publisher
Wiley
Online
2016-11-15
DOI
10.1002/cpt.568
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cannabinoids: Medical implications
- (2016) Richard J. Schrot et al. ANNALS OF MEDICINE
- Cannabinoids and autoimmune diseases: A systematic review
- (2016) Valeria Katchan et al. AUTOIMMUNITY REVIEWS
- Influence of Previous Failed Antispasticity Therapy on the Efficacy and Tolerability of THC:CBD Oromucosal Spray for Multiple Sclerosis Spasticity
- (2016) Michael Haupts et al. EUROPEAN NEUROLOGY
- The synthetic cannabinoid WIN55,212-2 mesylate decreases the production of inflammatory mediators in rheumatoid arthritis synovial fibroblasts by activating CB2, TRPV1, TRPA1 and yet unidentified receptor targets
- (2016) Torsten Lowin et al. Journal of Inflammation-London
- Marijuana-derived Δ-9-tetrahydrocannabinol suppresses Th1/Th17 cell-mediated delayed-type hypersensitivity through microRNA regulation
- (2016) Jessica M. Sido et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Efficacy and safety of cannabinoid oromucosal spray for multiple sclerosis spasticity
- (2016) F Patti et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Efficacy, tolerability and safety of cannabinoids in chronic pain associated with rheumatic diseases (fibromyalgia syndrome, back pain, osteoarthritis, rheumatoid arthritis)
- (2016) M.-A. Fitzcharles et al. SCHMERZ
- The cannabinoid quinol VCE-004.8 alleviates bleomycin-induced scleroderma and exerts potent antifibrotic effects through peroxisome proliferator-activated receptor-γ and CB2 pathways
- (2016) Carmen del Río et al. Scientific Reports
- Prenatal exposure to cannabis and maternal and child health outcomes: a systematic review and meta-analysis
- (2016) J K L Gunn et al. BMJ Open
- A systematic review of adverse events arising from the use of synthetic cannabinoids and their associated treatment
- (2015) Robert J. Tait et al. CLINICAL TOXICOLOGY
- Activation of cannabinoid receptor 2 attenuates synovitis and joint distruction in collagen-induced arthritis
- (2015) Huan Gui et al. IMMUNOBIOLOGY
- A CB2-Selective Cannabinoid Suppresses T-Cell Activities and Increases Tregs and IL-10
- (2015) Rebecca H. Robinson et al. Journal of Neuroimmune Pharmacology
- What has research over the past two decades revealed about the adverse health effects of recreational cannabis use?
- (2014) Wayne Hall ADDICTION
- Efficacy and safety of medical cannabinoids in older subjects: A systematic review
- (2014) G.A.H. van den Elsen et al. AGEING RESEARCH REVIEWS
- Cannabinoid receptor 2 as a potential therapeutic target in rheumatoid arthritis
- (2014) Shin Fukuda et al. BMC MUSCULOSKELETAL DISORDERS
- Neuroprotection in Experimental Autoimmune Encephalomyelitis and Progressive Multiple Sclerosis by Cannabis-Based Cannabinoids
- (2014) Gareth Pryce et al. Journal of Neuroimmune Pharmacology
- Anandamide Attenuates Th-17 Cell-Mediated Delayed-Type Hypersensitivity Response by Triggering IL-10 Production and Consequent microRNA Induction
- (2014) Austin R. Jackson et al. PLoS One
- Beneficial effect of the non-psychotropic plant cannabinoid cannabigerol on experimental inflammatory bowel disease
- (2013) Francesca Borrelli et al. BIOCHEMICAL PHARMACOLOGY
- Novel pebbles in the mosaic of autoimmunity
- (2013) Carlo Perricone et al. BMC Medicine
- Selective CB2 receptor activation ameliorates EAE by reducing Th17 differentiation and immune cell accumulation in the CNS
- (2013) Weimin Kong et al. CELLULAR IMMUNOLOGY
- Cannabis Induces a Clinical Response in Patients With Crohn's Disease: A Prospective Placebo-Controlled Study
- (2013) Timna Naftali et al. Clinical Gastroenterology and Hepatology
- Exogenous cannabinoids as substrates, inhibitors, and inducers of human drug metabolizing enzymes: a systematic review
- (2013) Stephen M. Stout et al. DRUG METABOLISM REVIEWS
- Marijuana Use Patterns Among Patients with Inflammatory Bowel Disease
- (2013) Jessica Ravikoff Allegretti et al. INFLAMMATORY BOWEL DISEASES
- Cannabinoids Decrease the Th17 Inflammatory Autoimmune Phenotype
- (2013) Ewa Kozela et al. Journal of Neuroimmune Pharmacology
- Effect of dronabinol on progression in progressive multiple sclerosis (CUPID): a randomised, placebo-controlled trial
- (2013) John Zajicek et al. LANCET NEUROLOGY
- Altered Expression of Type-1 and Type-2 Cannabinoid Receptors in Celiac Disease
- (2013) Natalia Battista et al. PLoS One
- The Cannabinoid Receptor type 2 Q63R variant increases the risk of celiac disease: Implication for a novel molecular biomarker and future therapeutic intervention
- (2012) Francesca Rossi et al. PHARMACOLOGICAL RESEARCH
- Drug Interactions between Common Illicit Drugs and Prescription Therapies
- (2012) Wesley T. Lindsey et al. AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE
- Differential migratory properties of monocytes isolated from human subjects naïve and non-naïve to Cannabis
- (2012) Michelle Sexton et al. INFLAMMOPHARMACOLOGY
- Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects
- (2011) Ethan B Russo BRITISH JOURNAL OF PHARMACOLOGY
- Cannabis Use in Patients with Fibromyalgia: Effect on Symptoms Relief and Health-Related Quality of Life
- (2011) Jimena Fiz et al. PLoS One
- Cannabidiol Reduces Intestinal Inflammation through the Control of Neuroimmune Axis
- (2011) Daniele De Filippis et al. PLoS One
- Targeting the Cannabinoid Pathway Limits the Development of Fibrosis and Autoimmunity in a Mouse Model of Systemic Sclerosis
- (2010) Amélie Servettaz et al. AMERICAN JOURNAL OF PATHOLOGY
- The Effects of Nabilone on Sleep in Fibromyalgia: Results of a Randomized Controlled Trial
- (2010) Mark A. Ware et al. ANESTHESIA AND ANALGESIA
- Do infections facilitate the emergence of systemic sclerosis?
- (2010) Chagai Grossman et al. AUTOIMMUNITY REVIEWS
- Geoepidemiology of autoimmune rheumatic diseases
- (2010) Yinon Shapira et al. Nature Reviews Rheumatology
- The cannabinoid receptor CB2 exerts antifibrotic effects in experimental dermal fibrosis
- (2009) Alfiya Akhmetshina et al. ARTHRITIS AND RHEUMATISM
- Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression
- (2009) Sadiye Amcaoglu Rieder et al. IMMUNOBIOLOGY
- Lack of effect of cannabis-based treatment on clinical and laboratory measures in multiple sclerosis
- (2009) Diego Centonze et al. NEUROLOGICAL SCIENCES
- Cannabinoids inhibit fibrogenesis in diffuse systemic sclerosis fibroblasts
- (2009) E. Garcia-Gonzalez et al. RHEUMATOLOGY
- Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb
- (2009) Angelo A. Izzo et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- The profile of immune modulation by cannabidiol (CBD) involves deregulation of nuclear factor of activated T cells (NFAT)
- (2008) Barbara L.F. Kaplan et al. BIOCHEMICAL PHARMACOLOGY
- Adverse effects of medical cannabinoids: a systematic review
- (2008) T. Wang et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- CB1 receptor antagonism: biological basis for metabolic effects
- (2008) Vincenzo Di Marzo DRUG DISCOVERY TODAY
- Characterisation of the cannabinoid receptor system in synovial tissue and fluid in patients with osteoarthritis and rheumatoid arthritis
- (2008) Denise Richardson et al. ARTHRITIS RESEARCH & THERAPY
- Nabilone for the Treatment of Pain in Fibromyalgia
- (2007) Ryan Quinlan Skrabek et al. JOURNAL OF PAIN
- Cannabidiol arrests onset of autoimmune diabetes in NOD mice
- (2007) Lola Weiss et al. NEUROPHARMACOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started